Specialty Pharmacy

Top news of the day from across the health care landscape.

Dietary intake of methionine and tryptophan may slow brain cancer tumor progression.

Single-cell method identifies core stem cells that cause leukemia within a tumor.

Pharmacists can aggressively intervene to adjust medications when patients’ diabetes is uncontrolled.

Higher consumer out-of-pocket costs could be a barrier to patient adoption of biosimilar drugs.

Ocrevus is a humanized monoclonal antibody that targets CD20-positive B cells in MS patients.

HCV testing rises in substance use disorder treatment programs.

Injections of new formulation of raltegravir may only be needed every month.

Ruptured cancerous cells are able to repair themselves to prevent cell death.

Top news of the day from across the health care landscape.

Multifaceted interventions with multiple members of the diabetes patient care team found more effective.

Work is still needed to achieve the significant promise of mobile health applications.

Specially synthesized plant peptide cyclotide found to suppress onset of multiple sclerosis.

Looming clinical trials offer hope for patients with Parkinson’s disease.

Study finds need for improved understanding of the association between rising systemic therapy use and the uptake of palliative care.

Inhibiting newly classified enzymes may lead to treatments for type 2 diabetes, inflammation, and autoimmune disease.

Cancer’s long-term side effects on fertility should be discussed with parents of young cancer patients.

Top news of the day from across the health care landscape.

Statins may reduce morbidity and/or mortality in COPD patients.

Inflectra biosimilar treats conditions such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.

Inhibiting GCN5 enzyme may lead to reduced remission risks and improved cure rates.

Program leads to estimated Medicare savings of $2650 for each enrollee over a 15-month period.

Top news of the day from across the health care landscape.

While PSA levels decreased in patients, overall survival did not improve in patients with non-metastatic prostate cancer.

New system could lead to advances in cancer investigation and drug discovery.

Study finds 15.5% of all psoriasis patients had undiagnosed psoriatic arthritis.

Lamivudine is designed to treat HIV-1 infection in combination with other antiretroviral agents.

Lamivudine is a nucleoside analogue reverse transcriptase inhibitor designed to treat HIV-1 infection in combination with other antiretroviral agents.